YinZhaoMD

Clinical Trials

• Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome Start of enrollment: 2018 Apr 11

  Recruiting

  Phase 2

• CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) Start of enrollment: 2020 Nov 23

  Active, not recruiting

  Phase 2

• Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) Start of enrollment: 2019 Apr 12

  Recruiting

  Phase 2

• A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD) Start of enrollment: 2021 Mar 31

  Completed

  Phase 2

• A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder Start of enrollment: 2023 Jun 30

  Terminated

  Phase 2

• Long-term Antipsychotic Pediatric Safety Trial Start of enrollment: 2019 Jan 10

  Completed

• A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD) Start of enrollment: 2016 Nov 21

  Terminated

  Phase 2

• Join now to see all